Ocugen (NASDAQ:OCGN) stock didn’t move much on a recent announcement that it had applied to the FDA for a new emergency use authorization (EUA) for the Covaxin coronavirus vaccine. Source: shutterstock.com/PhotobyTawat This EUA is for people between the ages of two and 18, but the move is extremely unlikely to prevent OCGN stock from sliding in
Shiba Inu (CCC:SHIB-USD) is in the headlines for mouthwatering gains in 2021. Social media influencers are becoming more active in voicing their opinions on volatile cryptocurrencies. Many of them are piling into meme coins. And we see the results with coins like Shiba Inu generating some serious momentum. Source: Wollertz / Shutterstock Cryptocurrency investing is rife
QuantumScape (NYSE:QS) stock may very well start soaring on the development of solid-state batteries and the company’s underlying innovation. Source: Michael Vi / Shutterstock.com Electric vehicles are the future. A commonly repeated mantra, it’s become such a meme that expressing a contrarian argument is sure to generate heat. However, some components of EVs are challenging,
Jeff Bezos, left, and Elon Musk Getty Images; Reuters The U.S. Federal Court of Claims ruled against Jeff Bezos’ Blue Origin in the company’s lawsuit versus NASA over a lucrative astronaut lunar lander contract awarded to Elon Musk’s SpaceX earlier this year. Federal judge Richard Hertling sided with the defense in his ruling, completing a
In this article QCOM QRVO Medical syringe is seen with Moderna company logo displayed on a screen in the background in this illustration photo taken in Poland. Jakub Porzycki | NurPhoto | Getty Images Check out the companies making headlines in midday trading. Moderna — Moderna shares tumbled 19% after a weaker-than-expected quarterly report. The drug
Palantir Technologies (NYSE:PLTR) hasn’t fully recovered since pulling back with the overall market in late September. But PLTR stock has still managed to slowly move higher in recent weeks. Source: Ascannio / Shutterstock.com To some extent, this uptrend makes sense. After all, the “story” behind this stock remains intact. The company has continued to post strong
The buy now, pay later (BNPL) market is red-hot, and related stocks are reaping the benefits or doubling down. Affirm Holdings (NASDAQ:AFRM) exploded from $50 to over $160 since May. Paidy was just acquired by PayPal (NASDAQ:PYPL) for $2.7 billion. Afterpay was acquired by Square (NYSE:SQ) in a $29 billion deal. Even Amazon (NASDAQ:AMZN), Target (NYSE:TGT)
You know a health savings account (HSA) helps pay for out-of-pocket medical costs, but it may surprise you to learn that this tax-advantaged account could be a superior retirement savings vehicle, too. It has become ingrained in us that we should max out our 401(k) or other workplace-defined contribution plan as the best way to
The renewable energy industry is booming. While it only supplies less than a quarter of the power generated today, this will change drastically by 2040. Its share is expected to grow in excess of 40% by 2040, as new technologies are developed for wind and solar energy production. Therefore, in line with the fast-changing energy
In this article F CZR SHOO Ford CEO Jim Farley poses with the Ford F-150 Lightning pickup truck in Dearborn, Michigan, May 19, 2021. Rebecca Cook | Reuters It seems each passing trading session brings a torrent of quarterly earnings and sharp swings for the stocks of the companies reporting results. Positive prints can have
A worker wields hinges to the company’s largest commercial asphalt paver at the Calder Brothers’ facility in Taylors, South Carolina, U.S., July 19, 2021. Brandon Granger | Calder Brothers Corporation | Reuters Hiring is expected to have picked up at a solid pace and wages likely continued to climb in October, as Covid receded and
Virgin Galactic (NYSE:SPCE) has been on a bad downward spiral. From a recent peak of $55.91 on June 25, SPCE stock is now near a low point of $19.55. However, despite this, don’t act on the urge just yet to bargain hunt in this stock. Source: rafapress / Shutterstock.com I forewarned investors that this could
Although all eyes have been on the searing path that benchmark equity indices have blazed in 2021, initial public offerings (IPOs) have had their own impressive bull market. In fact, Reuters reported in mid-June that U.S. IPOs hit an annual record in less than six months. So if 2020 was the year of the novel
It has been an excellent third-quarter earnings season so far. Of the S&P 500 stocks that have reported earnings, a majority have beaten analyst estimates. According to Factset Insight, 56% of the index companies have reported earnings so far in Q3 2021. Of those, 82% beat the consensus earnings per share (EPS). That’s higher than
In this article MAXR A close look at the primary mirror of a Worldview Legion satellite during assembly and inspection. Maxar Maxar Technologies‘ stock jumped on Thursday after reporting third-quarter results, with Wall Street analysts welcoming the space company’s progress toward the launch of key satellites next year. The company reported an adjusted EBITDA profit
Workers at Stellantis’ Detroit Assembly plant which produces the new 2021 Grand Cherokee L, a new three-row SUV. Michael Wayland | CNBC Broad-based strength in hiring in October signals the economy is shaking off the Covid-related slump of the third quarter and could grow faster than expected in the fourth quarter. Employment increased by 531,000
Ocugen (NASDAQ:OCGN) is a stock that I continue to be wrong about. Over the past month, OCGN stock has gained more than 80%, greatly testing my patience. The stock has fallen from the $17 mark it reached this morning, but is still higher than I expected last month. Source: shutterstock.com/PhotobyTawat In my last article about
When I last wrote about QuantumScape (NYSE:QS) in late September, I argued that if you could afford to lose it all, QS stock at $23.50 was in the buy zone. As I write this, it’s up 33% in the past month, trading above $30 for the first time since late June. Source: Michael Vi /
We highlight four ETFs that are benefitting from increasing adoption of automation & AI
Key Takeaways Berkshire Hathaway beat analysts’ expectations on earnings and revenues but missed on operating earnings. Gains on its investment portfolio were down YOY, but operating earnings from all segments except insurance were up. Insurance posted a larger underwriting loss than in Q3 2020. Revenues increased YOY across business segments, reflecting the conglomerate’s broad exposure